These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1637513

  • 1. Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial.
    Kamper AL, Strandgaard S, Leyssac PP.
    Am J Hypertens; 1992 Jul; 5(7):423-30. PubMed ID: 1637513
    [Abstract] [Full Text] [Related]

  • 2. [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial].
    Kamper AL, Strandgaard S, Leyssac PP.
    Ugeskr Laeger; 1993 Aug 02; 155(31):2406-9. PubMed ID: 8346593
    [Abstract] [Full Text] [Related]

  • 3. Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.
    Elung-Jensen T, Heisterberg J, Sonne J, Strandgaard S, Kamper AL.
    Eur J Clin Pharmacol; 2005 Apr 02; 61(2):87-96. PubMed ID: 15761754
    [Abstract] [Full Text] [Related]

  • 4. The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy.
    Kamper AL, Holstein-Rathlou NH, Leyssac PP, Strandgaard S.
    Am J Kidney Dis; 1996 Dec 02; 28(6):822-31. PubMed ID: 8957033
    [Abstract] [Full Text] [Related]

  • 5. Blood pressure response to conventional and low-dose enalapril in chronic renal failure.
    Elung-Jensen T, Heisterberg J, Kamper AL, Sonne J, Strandgaard S.
    Br J Clin Pharmacol; 2003 Feb 02; 55(2):139-46. PubMed ID: 12580985
    [Abstract] [Full Text] [Related]

  • 6. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May 02; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial.
    Ihle BU, Whitworth JA, Shahinfar S, Cnaan A, Kincaid-Smith PS, Becker GJ.
    Am J Kidney Dis; 1996 Apr 02; 27(4):489-95. PubMed ID: 8678058
    [Abstract] [Full Text] [Related]

  • 8. Enalapril versus metoprolol in primary hypertension--effects on the glomerular filtration rate.
    Aurell M, Bengtsson C, Björck S.
    Nephrol Dial Transplant; 1997 Nov 02; 12(11):2289-94. PubMed ID: 9394313
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy.
    Bauer JH, Reams GP, Hewett J, Klachko D, Lau A, Messina C, Knaus V.
    Am J Kidney Dis; 1992 Nov 02; 20(5):443-57. PubMed ID: 1442757
    [Abstract] [Full Text] [Related]

  • 10. Initial effect of enalapril on kidney function in patients with moderate to severe chronic nephropathy.
    Kamper AL, Thomsen HS, Nielsen SL, Strandgaard S.
    Scand J Urol Nephrol; 1990 Nov 02; 24(1):69-73. PubMed ID: 2157277
    [Abstract] [Full Text] [Related]

  • 11. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar 02; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 12. Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure.
    Hannedouche T, Landais P, Goldfarb B, el Esper N, Fournier A, Godin M, Durand D, Chanard J, Mignon F, Suo JM.
    BMJ; 1994 Oct 01; 309(6958):833-7. PubMed ID: 7950612
    [Abstract] [Full Text] [Related]

  • 13. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG, Apperloo AJ, Rensma PL, Stegeman CA, Sluiter WJ, de Zeeuw D, de Jong PE.
    Kidney Int Suppl; 1997 Dec 01; 63():S58-62. PubMed ID: 9407423
    [Abstract] [Full Text] [Related]

  • 14. Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and influence of proteinuria.
    Kamper AL, Strandgaard S, Leyssac PP.
    Nephrol Dial Transplant; 1995 Dec 01; 10(7):1182-8. PubMed ID: 7478121
    [Abstract] [Full Text] [Related]

  • 15. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G.
    Kidney Int; 1998 May 01; 53(5):1209-16. PubMed ID: 9573535
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study.
    Reyes-Marín FA, Calzada C, Ballesteros A, Amato D.
    Rev Invest Clin; 2012 May 01; 64(4):315-21. PubMed ID: 23227581
    [Abstract] [Full Text] [Related]

  • 17. Renal uptake of dimercaptosuccinic acid and glomerular filtration rate in chronic nephropathy at angiotensin converting enzyme inhibition.
    Kamper AL, Thomsen HS, Nielsen SL, Strandgaard S.
    Eur J Nucl Med; 1990 May 01; 16(2):85-8. PubMed ID: 2155787
    [Abstract] [Full Text] [Related]

  • 18. [Effect of enalapril on progression of chronic renal insufficiency caused by diabetes and other etiologies: a 2-year study].
    Trbojević J, Stojimirović B.
    Srp Arh Celok Lek; 2002 May 01; 130(3-4):87-90. PubMed ID: 12154520
    [Abstract] [Full Text] [Related]

  • 19. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.
    Kamper AL, Nielsen OJ.
    Scand J Clin Lab Invest; 1990 Oct 01; 50(6):611-8. PubMed ID: 2247767
    [Abstract] [Full Text] [Related]

  • 20. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.